Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases

References

• Anaya J-M, Corena R, Castiblanco J, Rojas-Villarraga A, Shoenfeld Y. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol. 2007;3(4):623–635. doi:10.1586/1744666X.3.4.623
   PubMedGoogle Scholar
• Anaya J-M. The autoimmune tautology. Arthritis Res Ther. 2010;12(6):147. doi:10.1186/ar3175
   Web of Science ®Google Scholar
• Selmi C, Brunetta E, Raimondo MG, Meroni PL. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev. 2012;11(6):A531–A537. doi:10.1016/j.autrev.2011.11.024
   Web of Science ®Google Scholar
• McCluskey P, Powell RJ. The eye in systemic inflammatory diseases. The Lancet. 2004;364(9451):2125–2133. doi:10.1016/S0140-6736(04)17554-5
   PubMed Web of Science ®Google Scholar
• Agustí A, Faner R. Systemic Inflammation and Comorbidities in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2012;9(2):43–46. doi:10.1513/pats.201108-050MS
   PubMedGoogle Scholar
• Generali E, Cantarini L, Selmi C. Ocular Involvement in Systemic Autoimmune Diseases. Clinic Rev Allerg Immunol. 2015;49(3):263–270. doi:10.1007/s12016-015-8518-3
   PubMed Web of Science ®Google Scholar
• Afshari NA, Afshari MA, Foster CS. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep. 2001;3(5):453–458. doi:10.1007/s11926-996-0017-3
   Google Scholar
• Troncoso LL, Biancardi AL. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol. 2017;23(32):5836–5848. doi:10.3748/wjg.v23.i32.5836
   PubMed Web of Science ®Google Scholar
• Foster CS, Forstot SL, Wilson LA. Mortality Rate in Rheumatoid Arthritis Patients Developing Necrotizing Scleritis or Peripheral Ulcerative Keratitis: effects of Systemic Immunosuppression. Ophthalmology. 1984;91(10):1253–1263. doi:10.1016/S0161-6420(84)34160-4
   PubMed Web of Science ®Google Scholar
• Riley GP, Harrall RL, Watson PG, Cawston TE, Hazleman BL. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye. 1995;9(6):703–718. doi:10.1038/eye.1995.182
   Web of Science ®Google Scholar
• Kemeny-Beke A, Szodoray P. Ocular manifestations of rheumatic diseases. Int Ophthalmol. 2020;40(2):503–510. doi:10.1007/s10792-019-01183-9
   PubMed Web of Science ®Google Scholar
• Varma R, Vajaranant TS, Burkemper B, et al. Visual Impairment and Blindness in Adults in the United States: demographic and Geographic Variations From 2015 to 2050. JAMA Ophthalmol. 2016;134(7):802–809. doi:10.1001/jamaophthalmol.2016.1284
   PubMed Web of Science ®Google Scholar
• Bourne RRA, Jonas JB, Bron AM, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2018;102(5):575–585. doi:10.1136/bjophthalmol-2017-311258
   PubMed Web of Science ®Google Scholar
• Akpek EK, Bunya VY, Saldanha IJ. Sjögren’s Syndrome: more Than Just Dry Eye. Cornea. 2019;38(5):658–661. doi:10.1097/ICO.0000000000001865
   PubMed Web of Science ®Google Scholar
• Kreutzmann A-K, Pannier S, Rojas-Perilla N, Schmid T, Templ M. The R Package emdi for Estimating and Mapping Regionally Disaggregated Indicators. J Stat Soft. 2019;91(7). doi:10.18637/jss.v091.i07
   Web of Science ®Google Scholar
• Levitt AE, McManus KT, McClellan AL, Davis JL, Goldhardt R, Galor A. Ocular Inflammation in the Setting of Concomitant Systemic Autoimmune Conditions in an Older Male Population. Cornea. 2015;34(7):762–767. doi:10.1097/ICO.0000000000000437
   PubMed Web of Science ®Google Scholar
• Ciurtin C, Cojocaru VM, Aramă S, Stoica V. Epidemiology of ocular involvement in autoimmune diseases. Rom J Intern Med. 2008;46(3):243–247.
   Google Scholar
• Ausayakhun S, Louthrenoo W, Aupapong S. Ocular diseases in patients with rheumatic diseases. J Med Assoc Thai. 2002;85(8):855–862.
   Google Scholar
• Pathanapitoon K, Tesavibul N, Choopong P, et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection. JAMA Ophthalmol. 2013;131(5):638–645. doi:10.1001/jamaophthalmol.2013.2860
   PubMed Web of Science ®Google Scholar
• Adelowo OO, Akpabio AA, Oderinlo O, Okonkwo ON, Raphael J. Case Series and Literature Review of Ophthalmologic Disorders Seen in a Specialist Rheumatology Clinic in Lagos, Nigeria. Ocul Immunol Inflamm. 2019;27(6):905–911. doi:10.1080/09273948.2019.1611873
   PubMed Web of Science ®Google Scholar
• Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis. J Rheumatol. 2020;48(1):25–34. doi:10.3899/jrheum.190768
   Web of Science ®Google Scholar
• Punjabi OS, Adyanthaya RS, Mhatre AD, Jehangir RP. Rheumatoid arthritis is a risk factor for dry eye in the Indian population. Ophthalmic Epidemiol. 2006;13(6):379–384. doi:10.1080/09286580600745969
   PubMed Web of Science ®Google Scholar
• Aboud S, Abd M. Ocular involvement and its manifestations in rheumatoid arthritis patients. Maedica. 2017;18:57–62. doi:10.4103/DJO.DJO_17_17
   Google Scholar
• Vignesh APP, Srinivasan R. Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies. Clin Ophthalmol. 2015;9:393–397. doi:10.2147/OPTH.S77210
   PubMed Web of Science ®Google Scholar
• Stenstam T. On the Occurrence of Keratoconjunctivitis Sicca in Cases of Rheumatoid Arthritis. Acta Med Scand. 1947;127(1–2):130–148. doi:10.1111/j.0954-6820.1947.tb13134.x
   Google Scholar
• Mody GM, Hill JC, Meyers OL. Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol. 1988;7(2):237–241. doi:10.1007/BF02204461
   Web of Science ®Google Scholar
• Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular Manifestations in Rheumatoid Arthritis. Maedica. 2010;5(4):286–291.
   PubMedGoogle Scholar
• Harper SL, Foster CS. The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin. 1998;38(1):1–19. doi:10.1097/00004397-199803810-00003
   Google Scholar
• Bhadoria DP, Bhadoria P, Sundaram KR, Panda A, Malaviya AN. Ocular manifestations of rheumatoid arthritis. J Indian Med Assoc. 1989;87(6):134–135.
   Google Scholar
• Lenoch F, Brémova A, Kankovax D, Streda A, Balik J. The Relation of SJögren’s Syndrome to Rheumatoid Arthritis. Acta Rheumatol Scand. 1964;10(1–4):297–304. doi:10.3109/rhe1.1964.10.issue-1-4.33
   PubMedGoogle Scholar
• Reddy SC, Gupta SD, Jain IS, Deodhar SD. Ocular manifestations of rheumatoid arthritis. Indian J Ophthalmol. 1977;25(3):20–26.
   Google Scholar
• Baer AN, Walitt B. Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults. Rheum Dis Clin North Am. 2018;44(3):419–436. doi:10.1016/j.rdc.2018.03.002
   PubMed Web of Science ®Google Scholar
• Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjögren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014;160(4):233–242. doi:10.7326/M13-1085
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Acar-Denizli N, Zeher M, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. 2017;76(6):1042–1050. doi:10.1136/annrheumdis-2016-209952
   PubMed Web of Science ®Google Scholar
• Parke AL, Buchanan WW. Sjögren’s syndrome: history, clinical and pathological features. Inflammopharmacology. 1998;6(4):271–287. doi:10.1007/s10787-998-0012-6
   Google Scholar
• Safonova TN, Iudina IV. Characteristics of keratoconjunctivitis sicca in Sjögren’s disease and syndrome. Ter Arkh. 1988;60(4):30–31.
   Web of Science ®Google Scholar
• Friedlaender MH. Ocular manifestations of Sjögren’s syndrome: keratoconjunctivitis sicca. Rheum Dis Clin North Am. 1992;18(3):591–608. doi:10.1016/S0889-857X(21)00318-5
   PubMed Web of Science ®Google Scholar
• Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135–149. doi:10.1007/s10238-017-0479-9
   PubMed Web of Science ®Google Scholar
• Papagiannuli E, Rhodes B, Wallace GR, Gordon C, Murray PI, Denniston AK. Systemic lupus erythematosus: an update for ophthalmologists. Surv Ophthalmol. 2016;61(1):65–82. doi:10.1016/j.survophthal.2015.06.003
   PubMed Web of Science ®Google Scholar
• Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100(1):135–141. doi:10.1136/bjophthalmol-2015-306629
   PubMed Web of Science ®Google Scholar
• Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898. doi:10.1155/2012/290898
   PubMedGoogle Scholar
• Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004;12(2):87–99. doi:10.1080/09273940490895308
   PubMed Web of Science ®Google Scholar
• Jensen JL, Bergem HO, Gilboe IM, Husby G, Axéll T. Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus. J Oral Pathol Med. 1999;28(7):317–322. doi:10.1111/j.1600-0714.1999.tb02047.x
   Web of Science ®Google Scholar
• Steinberg AD, Talal N. The coexistence of Sjögren’s syndrome and systemic lupus erythematosus. Ann Intern Med. 1971;74(1):55–61. doi:10.7326/0003-4819-74-1-55
   Web of Science ®Google Scholar
• Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum. 1988;31(9):1105–1110. doi:10.1002/art.1780310904
   PubMed Web of Science ®Google Scholar
• Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–1555. doi:10.1001/jama.2014.3266
   PubMed Web of Science ®Google Scholar
• Goldenberg DL. Fibromyalgia syndrome. An emerging but controversial condition. JAMA. 1987;257(20):2782–2787. doi:10.1001/jama.1987.03390200122026
   PubMed Web of Science ®Google Scholar
• Aykut V, Elbay A, Çigdem Uçar I, et al. Corneal sensitivity and subjective complaints of ocular pain in patients with fibromyalgia. Eye. 2018;32(4):763–767. doi:10.1038/eye.2017.275
   Web of Science ®Google Scholar
• Vehof J, Snieder H, Jansonius N, Hammond CJ. Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf. 2020. doi:10.1016/j.jtos.2020.04.005
   Web of Science ®Google Scholar
• Peponis V, Kyttaris V, Chalkiadakis S, Bonovas S, Sitaras N. Review: ocular side effects of anti-rheumatic medications: what a rheumatologist should know. Lupus. 2010;19(6):675–682. doi:10.1177/0961203309360539
   Web of Science ®Google Scholar
• Gilboe I-M, Kvien TK, Uhlig T, Husby G. Sicca symptoms and secondary Sjögren’s syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis. 2001;60(12):1103–1109. doi:10.1136/ard.60.12.1103
   Web of Science ®Google Scholar
• Brun JG, Madland TM, Jonsson R. A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Care Res. 2003;49(2):187–192. doi:10.1002/art.10999
   Web of Science ®Google Scholar
• Fousekis FS, Katsanos A, Katsanos KH, Christodoulou DK. Ocular manifestations in celiac disease: an overview. Int Ophthalmol. 2020;40(4):1049–1054. doi:10.1007/s10792-019-01254-x
   Web of Science ®Google Scholar
• Alarcón-Segovia D, Díaz-Jouanen E, Fishbein E. Features of Sjögren’s Syndrome in Primary Biliary Cirrhosis. Ann Intern Med. 1973;79(1):31–36. doi:10.7326/0003-4819-79-1-31
   Web of Science ®Google Scholar
• Gomes B, Santhiago MR, Magalhães P, Kara-Junior N. Ocular findings in patients with systemic sclerosis. Clinics. 2011;66(3):379–385. doi:10.1590/S1807-59322011000300003
   PubMed Web of Science ®Google Scholar
• Szucs G, Szekanecz Z, Aszalos Z, et al. A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis. Ocul Immunol Inflamm. 2019:1–9. doi:10.1080/09273948.2019.1657467
   Web of Science ®Google Scholar
• Tailor R, Gupta A, Herrick A, Kwartz J. Ocular Manifestations of Scleroderma. Surv Ophthalmol. 2009;54(2):292–304. doi:10.1016/j.survophthal.2008.12.007
   PubMed Web of Science ®Google Scholar
• Horan EC. Ophthalmic manifestations of progressive systemic sclerosis. Br J Ophthalmol. 1969;53(6):388–392. doi:10.1136/bjo.53.6.388
   PubMed Web of Science ®Google Scholar
• West RH, Barnett AJ. Ocular involvement in scleroderma. Br J Ophthalmol. 1979;63(12):845–847. doi:10.1136/bjo.63.12.845
   PubMed Web of Science ®Google Scholar
• Waszczykowska A, Goś R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P. Clinical researchPrevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci. 2013;9(6):1107–1113. doi:10.5114/aoms.2013.39217
   PubMed Web of Science ®Google Scholar
• Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52(9):2873–2881. doi:10.1002/art.21264
   PubMed Web of Science ®Google Scholar
• Lythgoe H, Almeida B, Bennett J, et al. Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management. Pediatric Rheumatol. 2018;16(1):80. doi:10.1186/s12969-018-0295-0
   Web of Science ®Google Scholar
• Allanore Y, Parc C, Monnet D, Brézin AP, Kahan A. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis. 2004;63(10):1276–1278. doi:10.1136/ard.2003.013540
   PubMed Web of Science ®Google Scholar
• Kim J-H, Joo Y-B, Kim J, Min J-K. A case of hypertrophic cranial pachymeningitis presenting with scleritis in a patient with undifferentiated connective tissue disease. J Korean Med Sci. 2010;25(6):966–969. doi:10.3346/jkms.2010.25.6.966
   PubMed Web of Science ®Google Scholar
• Protti A, Erminio C, Piccolo I, Spreafico C, Colombo F, Ghezzi A. An unusual case with relapsing neuromyelitis optica associated with undifferentiated connective tissue disease. Neurol Sci. 2004;25(Suppl 4):S383–385. doi:10.1007/s10072-004-0348-7
   Web of Science ®Google Scholar
• Colon LE, Enzenauer RJ. Corneal thinning as the sole manifestation of active undifferentiated connective tissue disease. South Med J. 1990;83(1):48–50. doi:10.1097/00007611-199001000-00015
   Web of Science ®Google Scholar
• Chylack LT, Bienfang DC, Bellows AR, Stillman JS. Ocular Manifestations of Juvenile Rheumatoid Arthritis. Am J Ophthalmol. 1975;79(6):1026–1033. doi:10.1016/0002-9394(75)90689-3
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007;46(6):1015–1019. doi:10.1093/rheumatology/kem053
   PubMed Web of Science ®Google Scholar
• Latif EMAE, Derini GFE. Study of the different ocular manifestations in children with juvenile idiopathic arthritis. J Egyptian Ophthalmol Soc. 2017;110(2):31. doi:10.4103/ejos.ejos_15_17
   Google Scholar
• EL-Shereef RR, Lofty G, Shawkat A. Ocular Manifestation of Juvenile Idiopathic Arthritis and its Relation to Disease Activity. J Arthritis. 2014;3(3):137. doi:10.4172/2167-7921.1000137
   Google Scholar
• Alarcon-Segovia D. Symptomatic Sjögren’s syndrome in mixed connective tissue disease. J Rheumatol. 1976;3(2):191–195.
   Web of Science ®Google Scholar
• Domngang Noche C, Kagmeni G, Dohvoma V, Bella AL, Ebana Mvogo C, Singwe-Ngandeu M. Ophthalmic Manifestations in Chronic Inflammatory Rheumatic Diseases at a Referral Hospital of Yaounde, Cameroon. Ocul Immunol Inflamm. 2018;26(2):259–264. doi:10.1080/09273948.2016.1212078
   PubMed Web of Science ®Google Scholar
• Graf WD, Milstein JM, Sherry DD. Stroke and mixed connective tissue disease. J Child Neurol. 1993;8(3):256–259. doi:10.1177/088307389300800309
   Web of Science ®Google Scholar
• Mimura T, Usui T, Amano S, et al. Retinal vasculitis and vitreous hemorrhage associated with mixed connective tissue disease: retinal vasculitis in MCTD. Int Ophthalmol. 2005;26(4–5):159–161. doi:10.1007/s10792-006-9015-8
   Google Scholar
• Nadeau SE. Neurologic manifestations of connective tissue disease. Neurol Clin. 2002;20(1):151–178. doi:10.1016/s0733-8619(03)00057-4
   Web of Science ®Google Scholar
• Hunter DG. Ocular manifestations of sarcoidosis. In: Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 1994:443–450.
   Google Scholar
• Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol. 1992;36(4):452–457.
   PubMed Web of Science ®Google Scholar
• Atmaca LS, Atmaca-Sönmez P, Idil A, Kumbasar OO, Celik G. Ocular involvement in sarcoidosis. Ocul Immunol Inflamm. 2009;17(2):91–94. doi:10.1080/09273940802596526
   PubMed Web of Science ®Google Scholar
• Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med. 2015;36(4):669–683. doi:10.1016/j.ccm.2015.08.009
   PubMed Web of Science ®Google Scholar
• Matsou A, Tsaousis KT. Management of chronic ocular sarcoidosis: challenges and solutions. Clin Ophthalmol. 2018;12:519–532. doi:10.2147/OPTH.S128949
   PubMed Web of Science ®Google Scholar
• Saari R, Lahti R, Saari KM, et al. Frequency of rheumatic diseases in patients with acute anterior uveitis. Scand J Rheumatol. 1982;11(2):121–123. doi:10.3109/03009748209098175
   PubMed Web of Science ®Google Scholar
• Stolwijk C. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(1):65–73. doi:10.1136/annrheumdis-2013-203582
   PubMed Web of Science ®Google Scholar
• Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008;67(7):955–959. doi:10.1136/ard.2007.075754
   PubMed Web of Science ®Google Scholar
• Marsovszky L, Németh J, Resch MD, et al. Corneal Langerhans cell and dry eye examinations in ankylosing spondylitis. Innate Immun. 2014;20(5):471–477. doi:10.1177/1753425913498912
   PubMed Web of Science ®Google Scholar
• Abbouda A, Abicca I, Fabiani C, et al. Psoriasis and Psoriatic Arthritis-Related Uveitis: different Ophthalmological Manifestations and Ocular Inflammation Features. Semin Ophthalmol. 2017;32(6):715–720. doi:10.3109/08820538.2016.1170161
   PubMed Web of Science ®Google Scholar
• Lima FBF, Abalem MF, Ruiz DG, et al. Prevalence of eye disease in Brazilian patients with psoriatic arthritis. Clinics. 2012;67(3):249–253. doi:10.6061/clinics/2012(03)08
   Web of Science ®Google Scholar
• Turk M, Hayworth J, Nevskaya T, Pope J. Sat0352 the Frequency of Ocular Manifestations in Patients with Adult Vs. Childhood Spondyloarthritis. Ann Rheum Dis. 2019;78(Suppl2):1256. doi:10.1136/annrheumdis-2019-eular.2434
   Web of Science ®Google Scholar
• Malaviya AN, Agrawal N, Patil NS. Clinical characteristics of peripheral spondyloarthritis without psoriasis, inflammatory enteropathy or preceding infection, from a single rheumatology clinic in northern India. Clin Rheumatol. 2017;36(11):2613–2618. doi:10.1007/s10067-017-3720-8
   Web of Science ®Google Scholar
• Mintz R, Feller ER, Bahr RL, Shah SA. Ocular Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2004;10(2):135–139. doi:10.1097/00054725-200403000-00012
   PubMed Web of Science ®Google Scholar
• Felekis T, Katsanos K, Kitsanou M, et al. Spectrum and Frequency of Ophthalmologic Manifestations in Patients with Inflammatory Bowel Disease: a Prospective Single-Center Study. Inflamm Bowel Dis. 2009;15(1):29–34. doi:10.1002/ibd.20584
   Web of Science ®Google Scholar
• Faez S, Lobo A-M, Unizony SH, Stone JH, Papaliodis GN, Sobrin L. Ocular inflammatory disease in patients with polymyalgia rheumatica: a case series and review of the literature. Clin Rheumatol. 2016;35(1):251–258. doi:10.1007/s10067-014-2558-6
   PubMed Web of Science ®Google Scholar
• Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical Characteristics of a Large Cohort of Patients with Scleritis and Episcleritis. Ophthalmology. 2012;119(1):43–50. doi:10.1016/j.ophtha.2011.07.013
   Web of Science ®Google Scholar
• Arai T, Tanaka R, Kaburaki T. Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: a Report of Three Cases. Ocul Immunol Inflamm. 2018;26(5):779–782. doi:10.1080/09273948.2017.1278776
   PubMed Web of Science ®Google Scholar
• Sobolewska B, Zierhut M. Dermatomyositis. In: Zierhut M, Pavesio C, Ohno S, Orefice F, Rao NA, editors. Intraocular Inflammation. Berlin, Heidelberg: Springer; 2016:815–819. doi:10.1007/978-3-540-75387-2_69
   Google Scholar
• Kahaly GJ, Diana T, Glang J, Kanitz M, Pitz S, König J. Thyroid Stimulating Antibodies Are Highly Prevalent in Hashimoto’s Thyroiditis and Associated Orbitopathy. J Clin Endocrinol Metab. 2016;101(5):1998–2004. doi:10.1210/jc.2016-1220
   PubMed Web of Science ®Google Scholar
• Kan E, Kılıçkan E, Ecemiş G, Beyazyildiz E, Çolak R. Presence of Dry Eye in Patients with Hashimoto’s Thyroiditis. J Ophthalmol. 2014;2014:754923. doi:10.1155/2014/754923
   Web of Science ®Google Scholar
• Altin Ekin M, Karadeniz Ugurlu S, Egrilmez ED, Oruk GG. Ocular Surface Changes in Hashimoto’s Thyroiditis Without Thyroid Ophthalmopathy. Eye Contact Lens. 2020. doi:10.1097/ICL.0000000000000686
   Web of Science ®Google Scholar
• Gharib S, Moazezi Z, Bayani MA. Prevalence and severity of ocular involvement in Graves’ disease according to sex and age: a clinical study from Babol, Iran. Caspian J Intern Med. 2018;9(2):178–183. doi:10.22088/cjim.9.2.178
   PubMed Web of Science ®Google Scholar
• Tanda ML, Piantanida E, Liparulo L, et al. Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed graves’ hyperthyroidism seen at a single center. J Clin Endocrinol Metab. 2013;98(4):1443–1449. doi:10.1210/jc.2012-3873
   PubMed Web of Science ®Google Scholar
• Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92–108. doi:10.4239/wjd.v6.i1.92
   PubMed Web of Science ®Google Scholar
• Ljubimov AV. Diabetic complications in the cornea. Vision Res. 2017;139:138–152. doi:10.1016/j.visres.2017.03.002
   PubMed Web of Science ®Google Scholar
• Cousen P, Cackett P, Bennett H, Swa K, Dhillon B. Tear production and corneal sensitivity in diabetes. J Diabetes Complicat. 2007;21(6):371–373. doi:10.1016/j.jdiacomp.2006.05.008
   PubMed Web of Science ®Google Scholar
• Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the “primary” antiphospholipid syndrome. Ann Rheum Dis. 1989;48(5):358–361. doi:10.1136/ard.48.5.358
   Web of Science ®Google Scholar
• Demirci FY, Küçükkaya R, Akarçay K, et al. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS. Int Ophthalmol. 1998;22(6):323–329. doi:10.1023/a:1006305705080
   PubMed Web of Science ®Google Scholar
• Cervera R, Boffa M-C, Khamashta MA, Hughes GRV. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18(10):889–893. doi:10.1177/0961203309106832
   PubMed Web of Science ®Google Scholar
• Castañón C, Amigo M-C, Bañales JL, Nava A, Reyes PA. Ocular Vaso-occlusive Disease in Primary Antiphospholipid Syndrome. Ophthalmology. 1995;102(2):256–262. doi:10.1016/S0161-6420(95)31028-7
   Web of Science ®Google Scholar
• Yehudai D, Shoenfeld Y, Toubi E. Looking into the eyes of patients with antiphospholipid syndrome. Clin Rev Allergy Immunol. 2007;32(2):192–197. doi:10.1007/s12016-007-0002-2
   Web of Science ®Google Scholar
• Pulido JS, Ward LM, Fishman GA, Goodwin JA, Froelich CJ, Sanghvi JP. Antiphospholipid antibodies associated with retinal vascular disease. Retina. 1987;7(4):215–218. doi:10.1097/00006982-198707040-00002
   Web of Science ®Google Scholar
• Levine SR, Brey RL. Neurological aspects of antiphospholipid antibody syndrome. Lupus. 1996;5(5):347–353. doi:10.1177/096120339600500503
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol. 2001;131(4):451–456. doi:10.1016/S0002-9394(00)00884-9
   PubMed Web of Science ®Google Scholar
• Takkar B, Khokhar S, Kumar U, Venkatesh P. Necrotising scleritis, keratitis and uveitis in primary antiphospholipid syndrome. BMJ Case Rep. 2018;2018. doi:10.1136/bcr-2017-220647
   Google Scholar
• Majji AB, Bhatia K, Mathai A. Spontaneous bilateral peripapillary, subhyaloid and vitreous hemorrhage with severe anemia secondary to idiopathic thrombocytopenic purpura. Indian J Ophthalmol. 2010;58(3):234–236. doi:10.4103/0301-4738.62651
   Web of Science ®Google Scholar
• Shah PA, Yang SS, Fung WE. Idiopathic Thrombocytopenic Purpura With Massive Subretinal Hemorrhage. Arch Ophthalmol. 2005;123(11):1612–1613. doi:10.1001/archopht.123.11.1612
   Google Scholar
• Awh CC, Modjtahedi BS, Eliott D. Purtscher’s retinopathy as the presenting manifestation of immune thrombocytopenic purpura. Am J Ophthalmol Case Rep. 2017;6:77–80. doi:10.1016/j.ajoc.2017.03.001
   Google Scholar
• Chiu S, Lim B, Chan N Progressive Retinopathy In Adult Onset Idiopathic Thrombocytopenia Purpura. 2005. Available from: https://www.aaopt.org/detail/knowledge-base-article/progressive-retinopathy-adult-onset-idiopathic-thrombocytopenia-purpura. Accessed July 6, 2020.
   Google Scholar
• Karagiannis D, Gregor Z. Valsalva retinopathy associated with idiopathic thrombocytopenic purpura and positive antiphospholipid antibodies. Eye. 2006;20(12):1447–1449. doi:10.1038/sj.eye.6702313
   Web of Science ®Google Scholar
• Honig SE, Srinivasan A, Shields CL. Suprachoroidal Hemorrhage Simulating Melanoma in Idiopathic Thrombocytopenic Purpura. Ocul Oncol Pathol. 2019;5(3):162–166. doi:10.1159/000490390
   Web of Science ®Google Scholar
• Foulds WS, Chisholm IA, Stewart JB, Wilson TM. The Optic Neuropathy of Pernicious Anemia. Arch Ophthalmol. 1969;82(4):427–432. doi:10.1001/archopht.1969.00990020429001
   Google Scholar
• Hamilton HE, Ellis PP, Sheets RF. Visual Impairment due to Optic Neuropathy in Pernicious Anemia: report of a Case and Review of the Literature. Blood. 1959;14(4):378–385. doi:10.1182/blood.V14.4.378.378
   Web of Science ®Google Scholar
• Troncoso J, Mancall EL, Schatz NJ. Visual Evoked Responses in Pernicious Anemia. Arch Neurol. 1979;36(3):168–169. doi:10.1001/archneur.1979.00500390086010
   Google Scholar
• Lerman S, Feldmahn AL. Centrocecal Scotomata as the Presenting Sign in Pernicious Anemia. Arch Ophthalmol. 1961;65(3):381–385. doi:10.1001/archopht.1961.01840020383011
   Google Scholar
• Ellis PP, Hamilton H. Retrobulbar Neuritis in Pernicious Anemia*. Am J Ophthalmol. 1959;48(1):95–97. doi:10.1016/0002-9394(59)90291-0
   Web of Science ®Google Scholar
• Chew FLM, Tajunisah I. Retinal phlebitis associated with autoimmune hemolytic anemia. Ocul Immunol Inflamm. 2009;17(6):394–395. doi:10.3109/09273940903260204
   Web of Science ®Google Scholar
• Oner A, Ozkiris A, Dogan H, Erkilic K, Karakukcu M. BILATERAL MACULAR HEMORRHAGE ASSOCIATED WITH AUTOIMMUNE HEMOLYTIC ANEMIA. RETINA. 2005;25(8):1089–1090. doi:10.1097/00006982-200512000-00018
   Web of Science ®Google Scholar
• Sharma A, Dhooria A, Aggarwal A, Rathi M, Chandran V. Connective Tissue Disorder-Associated Vasculitis. Curr Rheumatol Rep. 2016;18(6):31. doi:10.1007/s11926-016-0584-x
   Web of Science ®Google Scholar
• Schmidt D, Lagrèze W, Vaith P. Ophthalmoscopic findings in 3 patients with panarteritis nodosa and review of the literature. Klin Monbl Augenheilkd. 2001;218(1):44–50. doi:10.1055/s-2001-11260
   Web of Science ®Google Scholar
• Akova YA, Jabbur NS, Foster CS. Ocular Presentation of Polyarteritis Nodosa: clinical Course and Management with Steroid and Cytotoxic Therapy. Ophthalmology. 1993;100(12):1775–1781. doi:10.1016/S0161-6420(93)31405-3
   Web of Science ®Google Scholar
• Miyanaga M, Takase H, Ohno-Matsui K. Anti-Neutrophil Cytoplasmic Antibody-Associated Ocular Manifestations in Japan: a Review of 18 Patients. Ocul Immunol Inflamm. 2020;1–6. doi:10.1080/09273948.2020.1712432
   Web of Science ®Google Scholar
• Razzak A, Kassimi A, Mchachi A, et al. Œil et Maladie de Behçet: profil épidémiologique, clinique, thérapeutique et évolutif. Pan Afr Med J. 2019;33. doi:10.11604/pamj.2019.33.116.17111
   Web of Science ®Google Scholar
• Paovic J, Paovic P, Sredovic V. Behcet’s Disease: systemic and Ocular Manifestations. Biomed Res Int. 2013;2013. doi:10.1155/2013/247345
   PubMed Web of Science ®Google Scholar
• Cullen JF, Coleiro JA. Ophthalmic complications of giant cell arteritis. Surv Ophthalmol. 1976;20(4):247–260. doi:10.1016/0039-6257(76)90224-1
   PubMedGoogle Scholar
• McCluskey P, Powell RJ. The eye in systemic inflammatory diseases. The Lancet. 2004;364(9451):2125–2133. doi:10.1016/S0140-6736(04)17554-5
   PubMed Web of Science ®Google Scholar
• Sook Chun Y, Park S-J, Kipark I, Chung H, Lee J. THE CLINICAL AND OCULAR MANIFESTATIONS OF TAKAYASU ARTERITIS. RETINA. 2001;21(2):132–140. doi:10.1097/00006982-200104000-00006
   Web of Science ®Google Scholar
• Muqit MMK, Gallagher MJ, Gavin M, Roberts F, Jardine AG. Henoch-Schonlein purpura with keratitis and granulomatous anterior uveitis. Br J Ophthalmol. 2005;89(9):1221–1222. doi:10.1136/bjo.2004.064519
   Web of Science ®Google Scholar
• Chuah J, Meaney T. Anterior ischaemic optic neuropathy secondary to Henoch–Schönlein Purpura. Eye. 2005;19(9):1028. doi:10.1038/sj.eye.6701764
   Web of Science ®Google Scholar
• Nicholson L, Mathews D. Bilateral cystoid macular oedema and cotton wool spots associated with Henoch-Schonlein purpura. Case Reports. 2013;2013:bcr2013200159. doi:10.1136/bcr-2013-200159
   Google Scholar
• Lorentz WB, Weaver RG. Eye Involvement in Anaphylactoid Purpura. Am J Dis Child. 1980;134(5):524–525. doi:10.1001/archpedi.1980.02130170074027
   Google Scholar
• Erbagci I, Erbagci Z, Gungor K, Bekir N. Ocular anterior segment pathologies and tear film changes in patients with psoriasis vulgaris. Acta Med Okayama. 2014.
   Google Scholar
• Chandran NS, Greaves M, Gao F, Lim L, Cheng BCL. Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis. J Dermatol. 2007;34(12):805–810. doi:10.1111/j.1346-8138.2007.00390.x
   PubMed Web of Science ®Google Scholar
• Reed WB, Becker SW. Psoriasis and Arthritis. AMA Arch Derm. 1960;81(4):577–585. doi:10.1001/archderm.1960.03730040081015
   Google Scholar
• Cruz NFSD, Brandão LS, Cruz SFSD, Cruz SASD, Pires CAA, Carneiro FRO. Ocular manifestations of psoriasis. Arq Bras Oftalmol. 2018;81(3):219–225. doi:10.5935/0004-2749.20180044
   Web of Science ®Google Scholar
• Baskan EB, Baykara M, Ercan İ, Tunali S, Yucel A. Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol. 2006;20(7):829–833. doi:10.1111/j.1468-3083.2006.01655.x
   Web of Science ®Google Scholar
• Biswas G, Barbhuiya JN, Biswas MC, Islam MN, Dutta S. Clinical pattern of ocular manifestations in vitiligo. J Indian Med Assoc. 2003;101(8):478–480.
   Google Scholar
• Dogan AS, Atacan D, Durmazlar SPK, Acar M, Gurdal C. Evaluation of dry eye findings in patients with vitiligo. Pak J Med Sci. 2015;31(3):587–591. doi:10.12669/pjms.313.6926
   Web of Science ®Google Scholar
• España A, Iranzo P, Herrero‐González J, Mascaro JM, Suárez R. Ocular involvement in pemphigus vulgaris – a retrospective study of a large Spanish cohort. JDDG. 2017;15(4):396–403. doi:10.1111/ddg.13221
   Google Scholar
• Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527–663.
   PubMedGoogle Scholar
• Citirik M, Berker N, Kacar S, Kekilli M. Ocular Findings in Patients with Autoimmune Liver Disease. Ocul Immunol Inflamm. 2012;20(6):438–442. doi:10.3109/09273948.2012.719994
   PubMed Web of Science ®Google Scholar
• Kamal A, Bhan A, Murray PI. Uveitis with autoimmune hepatic disorders. Ocul Immunol Inflamm. 2001;9(4):267–272. doi:10.1076/ocii.9.4.267.3960
   PubMed Web of Science ®Google Scholar
• The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol. 1991;109(12):1673–1678. doi:10.1001/archopht.1991.01080120057025
   PubMedGoogle Scholar
• Atkins EJ, Biousse V, Newman NJ. Optic neuritis. Semin Neurol. 2007;27(3):211–220. doi:10.1055/s-2007-979683
   Web of Science ®Google Scholar
• Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005;4(5):281–288. doi:10.1016/S1474-4422(05)70071-5
   PubMed Web of Science ®Google Scholar
• Graves J, Balcer LJ. Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol. 2010;4:1409–1422. doi:10.2147/OPTH.S6383
   PubMedGoogle Scholar
• Müri RM, Meienberg O. The Clinical Spectrum of Internuclear Ophthalmoplegia in Multiple Sclerosis. Arch Neurol. 1985;42(9):851–855. doi:10.1001/archneur.1985.04060080029011
   PubMedGoogle Scholar
• Kardes E, Sezgin Akcay BI, Bozkurt K, Unlu C, Erdogan G, Akcali G. Clinical characteristics of intermediate uveitis in adult Turkish patients. Int J Ophthalmol. 2015;8(4):759–763. doi:10.3980/j.issn.2222-3959.2015.04.21
   Web of Science ®Google Scholar
• Nilsson P, Larsson E-M, Maly-Sundgren P, Perfekt R, Sandberg-Wollheim M. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up. J Neurol. 2005;252(4):396–402. doi:10.1007/s00415-005-0655-9
   PubMed Web of Science ®Google Scholar
• Merabtene L, Vignal Clermont C, Deschamps R. Neuropathie optique dans le syndrome des anticorps anti MOG positif. J Français d’Ophtalmologie. 2019;42(10):1100–1110. doi:10.1016/j.jfo.2019.06.006
   PubMed Web of Science ®Google Scholar
• Levin MH, Bennett JL, Verkman AS. OPTIC NEURITIS IN NEUROMYELITIS OPTICA. Prog Retin Eye Res. 2013;36:159–171. doi:10.1016/j.preteyeres.2013.03.001
   PubMed Web of Science ®Google Scholar
• Sun H, Cui S, Gao F, et al. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder. J Neurol Sci. 2018;384:91–95. doi:10.1016/j.jns.2017.11.033
   Web of Science ®Google Scholar
• Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30. doi:10.1038/s41572-019-0079-y
   PubMed Web of Science ®Google Scholar
• Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023–1036. doi:10.1016/S1474-4422(15)00145-3
   PubMed Web of Science ®Google Scholar
• Roh HS, Lee SY, Yoon JS. Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis. Korean J Ophthalmol. 2011;25(1):1–7. doi:10.3341/kjo.2011.25.1.1
   Google Scholar
• Wang T-J, Wang I-J, Hu -C-C, Lin H-C. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol. 2012;90(7):663–668. doi:10.1111/j.1755-3768.2010.01993.x
   PubMed Web of Science ®Google Scholar
• Zdebik N, Zdebik A, Bogusławska J, Przeździecka-Dołyk J, Turno-Kręcicka A. Fibromyalgia Syndrome and Eye – a review. Surv Ophthalmol. 2020. doi:10.1016/j.survophthal.2020.05.006
   Web of Science ®Google Scholar
• Fan N, Florakis G. Scleritis Associated with the Fibromyalgia Syndrome. Cornea. 1996;15(6):637–638. doi:10.1097/00003226-199611000-00017
   Web of Science ®Google Scholar
• Chow K, Emara B. Necrotizing scleritis and fibromyalgia: a potential link? Can J Ophthalmol. 2008;43(1):117–118. doi:10.3129/i07-207
   Web of Science ®Google Scholar
• Pilar Bambo M, Garcia-Martin E, Gutierrez-Ruiz F, et al. Study of perfusion changes in the optic disc of patients with fibromyalgia syndrome using new colorimetric analysis software. J Français d’Ophtalmologie. 2015;38(7):580–587. doi:10.1016/j.jfo.2015.01.010
   Web of Science ®Google Scholar